Speciation and Characterization of Mycobacterium Tuberculosis Complex Isolated from Multi-Drug Resistance Tuberculosis Patients in Southeastern Nigeria
DOI:
https://doi.org/10.60787/tnhj-707Keywords:
Mycobacterium tuberculosis complex, species, MDR-TB and Diagnosis, NigeriaAbstract
In Nigeria and other low-and-middle-income countries, majority of clinical laboratories use Gene Xpert MTB/RIF assay, Hain lifescience MTBDRplus and MTBDRsl for rapid diagnosis of both TB and MDR-TB. These tools diagnose TB disease caused by members of Mycobacterium tuberculosis complex (MTBC), but do not differentiate among members of the MTBC to the species level. Knowledge of the circulating strains of MTBC in a population is critical for effective TB control measures. In this study, 96 MDR-TB strains isolated from patients in Southeast Nigeria were differentiated to species level using Geno Type MTBC kit. Of the 96, 58.30% (n=56) were M. tuberculosis/M. canettii, 11.45% (n=11) were M. africanum and 2.10% (n=2) were M. bovis. However, 11.45% (n=11) were high gram-positive bacteria, 14.60% (n=14) were invalid, while 2.10% (n=2) had no evaluable pattern. Our findings shows that M. tuberculosis/M. canettii and M. africanum are the leading cause of MDR-TB in Southeast Nigeria. Our findings show that M tuberculosis/M. canettii and M. africanum are the leading causes of MDR-TB amongst the study population. Furthermore, the results of this study indicate that M. bovis remains an important cause of tuberculosis particularly amongst groups at risk.
References
Asare P, Asante-Poku A, Osei-Wusu S, Otchere ID, Yeboah-Manu D. The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa. Front Public Heal. 2021;9:1–17.
Sylverken AA, Kwarteng A, Twumasi-Ankrah S, Owusu M, Arthur RA, Dumevi RM, et al. The burden of drug resistance tuberculosis in Ghana; results of the First National Survey. PLoS One [Internet]. 2021;16(6 June):1–14. Available from: http://dx.doi.org/10.1371/journal.pone.0252819
Miller MA, Buss P, Roos EO, Hausler G, Dippenaar A, Mitchell E, et al. Fatal tuberculosis in a free-ranging African elephant and one health implications of human pathogens in wildlife. Front Vet Sci. 2019; 6:1–8.
Tomeny EM, Nightingale R, Chinoko B, Nikolaidis GF, Madan JJ, Worrall E, et al. TB morbidity estimates overlook the contribution of post-TB disability: Evidence from urban Malawi. BMJ Glob Heal. 2022;7(5):1–12.
Živanović I, Vuković D, Dakić I, Savić B. Species of mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens from Serbia. Arch Biol Sci. 2014;66(2):553–61.
Brites D, Loiseau C, Menardo F, Borrell S, Boniotti MB, Warren R, et al. A New Phylogenetic Framework for the Animal-Adapted Mycobacterium tuberculosis Complex. 2018;9 :1–14.
Federal Ministral of Health (FMoH). Department of Public Health. National Tuberculosis and Leprosy Control Programme. National Guidelines for Culture and Drug Susceptibility Testing.
Abuja, Nigeria, December 2015. Available from https://ntblcp.org.ng/resources/national-guidelines-for-culture-and-drug-susceptibility-testing/
Cá B, Fonseca KL, Sousa J, Maceiras AR, Machado D, Sanca L, et al. Experimental Evidence for Limited in vivo Virulence of Mycobacterium africanum. Front Microbiol. 2019;10 :1–9.
Blouin Y, Cazajous G, Dehan C, Soler C, Vong R, Hassan MO, et al. Progenitor “Mycobacterium canettii” Clone responsible for lymph node tuberculosis epidemic, Djibouti. Emerg Infect Dis. 2014;20(1):21–8.
Bakuła Z, Wuyep VB, Bartocha Ł, Vyazovaya A, Ikeh EI, Bielecki J, et al. Molecular snapshot of drug-resistant Mycobacterium tuberculosis strains from the Plateau State, Nigeria. PLoS One [Internet]. 2022;17(5 May):1–13. Available from: http://dx.doi.org/10.1371/journal.pone.0266837
Chuku A, Ajide B, Lawson L, Orule K, Adogo L. Differentiation and Characterization of Mycobacterium tuberculosis Complex Causing Pulmonary Tuberculosis across North Central Nigeria. Int J Trop Dis Heal. 2019 :1–10.
Osei-wusu S, Otchere ID, Asare P, Ntoumi F, Zumla A, Asante-poku A, et al. International Journal of Infectious Diseases Relevance of genomic diversity of Mycobacterium tuberculosis complex in Africa. Int J Infect Dis [Internet]. 2022;124:S47–9. Available from: https://doi.org/10.1016/j.ijid.2022.03.016
Asante-poku A, Otchere ID, Osei-wusu S, Sarpong E, Baddoo A, Forson A, et al. Molecular epidemiology of Mycobacterium africanum in Ghana. BMC Infect Dis [Internet]. 2016;1–8. Available from: http://dx.doi.org/10.1186/s12879-016-1725-6
Ofori-anyinam B, Kanuteh F, Agbla SC. Impact of the Mycobaterium africanum West Africa 2 Lineage on TB Diagnostics in West Africa : Decreased Sensitivity of Rapid Identification Tests in The Gambia. 2016;1–12.
Adesokan HK, Jenkins AO, Soolingen D Van, Cadmus SIB. Mycobacterium bovis infection in livestock workers in Ibadan , Nigeria : evidence of occupational exposure. 2012;16:1388–92.
Sa'idu AS, Okolocha EC, Dzikwi AA, Gamawa AA, Ibrahim S, Kwaga JKP, et al. Public Health Implications and Risk Factors Assessment of Mycobacterium bovis Infections among Abattoir Personnel in Bauchi State, Nigeria. Journal of Veterinary Medicine 2015; Vol. 2015. Article ID 718193. Available from https://doi.org/10.1155/2015/718193
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal and Publisher
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
